Jim Barrington appointed Chief Information Officer at Novartis
January 30, 2004 02:00 ET
|
Novartis Pharma AG
Jim Barrington appointed Chief Information Officer at NovartisBasel, 30 January 2004 - Novartis announced today the appointment of Jim Barrington as Chief Information Officer of the Novartis Group...
Novartis beantragt weltweit Zulassung für führenden Blutdruck-senker Diovan®, um Überleben von Hochrisiko-patienten nach Herz-infarkt zu verbessern und Herz-Kreislauf-Ereignisse zu reduzieren
January 30, 2004 02:00 ET
|
Novartis Pharma AG
Basel, 30. Januar 2004 - Novartis Pharma AG gibt heute bekannt, dass sie bei den Behörden verschiedener Länder ein Zulassungsgesuch für eine Neuindikation für Diovan (Valsartan) eingereicht hat. Ziel...
Novartis Files Application for New Indication for Diovan
January 30, 2004 01:37 ET
|
Novartis
BASEL, Switzerland, Jan. 30, 2004 (PRIMEZONE) -- Novartis Pharma AG announced it has filed an application to various regulatory authorities for a new indication for Diovana (valsartan) to improve...
Novartis files application for new indication for Diovan®
January 30, 2004 01:30 ET
|
Novartis Pharma AG
Novartis files global marketing application for its leading high blood pressure drug Diovan®, to improve survival and reduce cardiovascular events in high-risk patients following a heart...
Novartis dépose une d'AMM pour une nouvelle indication de Diovan®
January 30, 2004 01:30 ET
|
Novartis Pharma AG
Anti-hypertenseur phare de Novartis, Diovan® fait l'objet d'une demande d'AMM au niveau mondial pour améliorer la survie et réduire les incidents cardiovasculaires chez les patients à haut risque...
Novartis reicht Zulassungsgesuch für Neuindikation für Diovan® ein
January 30, 2004 01:30 ET
|
Novartis Pharma AG
Novartis beantragt weltweit Zulassung für führenden Blutdrucksenker Diovan®, um Überleben von Hochrisikopatienten nach Herzinfarkt zu verbessern und Herz-Kreislauf-Ereignisse zu...
Sika festigt die Position in Osteuropa
January 29, 2004 23:00 ET
|
Sika AG
Duna-Dráva Cement ist ein Joint-Venture der beiden deutschen Unternehmen HeidelbergCement und Schwenk Cement, die je 50% der Aktien halten. Beide Unternehmensgruppen haben sich im Rahmen einer...
Sika solidifies its position in Eastern Europe
January 29, 2004 23:00 ET
|
Sika AG
Duna-Dráva is a 50-50 joint venture of two German companies, HeidelbergCement and Schwenk Cement. In a shift of focus these companies have already withdrawn from the concrete admixtures business. The...
Massive 1 Week Supersale At Go-Today.com!!!
January 29, 2004 20:04 ET
|
go-today.com
BOTHELL, Wash., Jan. 29, 2004 (PRIMEZONE) -- This is the height of vacation excitement! At Go-Today.com we now have newly reduced, one-chance specials that are only available for a few days, so make...
Photo Release -- Blue Fox Re-defines Fur Design This Season
January 29, 2004 18:45 ET
|
Saga Furs of Scandinavia
NEW YORK, Jan. 29, 2004 (PRIMEZONE) -- As New York Fashion Week approaches (2/6/04-2/13/04), 'fashionistas' should expect to see the return of an old fur favorite on designer runways. Blue fox, a...
- December 26, 2024 21:19 ET Faruqi & Faruqi Reminds ASP Isotopes Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 3, 2025 – ASPI
- December 26, 2024 21:03 ET Faruqi & Faruqi Reminds DMC Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 4, 2025 – BOOM